Give support

Do you think that a friend or family member might have a liver disease? Or has a friend or family member of yours recently been diagnosed with a liver disease such as hepatic encephalopathy? You probably have many questions and would like to better understand the conditions. This page will give you an initial overview, but it cannot  replace consulting a doctor.

Obligatory texts Hepa-Merz®

EU:

Hepa- Merz®  Granules
Active substance: L-ornithine- L-aspartate
Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose,

For risks and side effects please read package insert and ask your doctor or pharmacist.

Version July 2019


Merz Pharmaceuticals GmbH, 60048 Frankfurt

LATAM:

Hepa- Merz®  Granules
Active substance: L-ornithine- L-aspartate
Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose, aspartame.

For risks and side effects please read package insert and ask your doctor or pharmacist.

Version July 2019


Merz Pharmaceuticals GmbH, 60048 Frankfurt